Wheeler DL - Search Results

1

Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor.

Iida M, Brand TM, Campbell DA, Li C, Wheeler DL. Iida M, et al. Among authors: wheeler dl. Oncogene. 2013 Feb 7;32(6):759-67. doi: 10.1038/onc.2012.90. Epub 2012 Mar 19. Oncogene. 2013. PMID: 22430206 Free PMC article.

2

Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.

Wheeler DL, Reddig PJ, Dreckschmidt NE, Leitges M, Verma AK. Wheeler DL, et al. Oncogene. 2002 May 16;21(22):3620-30. doi: 10.1038/sj.onc.1205451. Oncogene. 2002. PMID: 12032864

3

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members.

Wheeler DL, Huang S, Kruser TJ, Nechrebecki MM, Armstrong EA, Benavente S, Gondi V, Hsu KT, Harari PM. Wheeler DL, et al. Oncogene. 2008 Jun 26;27(28):3944-56. doi: 10.1038/onc.2008.19. Epub 2008 Feb 25. Oncogene. 2008. PMID: 18297114 Free PMC article.

4

Molecular target approaches in head and neck cancer: epidermal growth factor receptor and beyond.

Harari PM, Wheeler DL, Grandis JR. Harari PM, et al. Among authors: wheeler dl. Semin Radiat Oncol. 2009 Jan;19(1):63-8. doi: 10.1016/j.semradonc.2008.09.009. Semin Radiat Oncol. 2009. PMID: 19028347 Free PMC article. Review.

5

Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cells.

Benavente S, Huang S, Armstrong EA, Chi A, Hsu KT, Wheeler DL, Harari PM. Benavente S, et al. Among authors: wheeler dl. Clin Cancer Res. 2009 Mar 1;15(5):1585-92. doi: 10.1158/1078-0432.CCR-08-2068. Epub 2009 Feb 3. Clin Cancer Res. 2009. PMID: 19190133 Free PMC article.

6

Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximab.

Wheeler DL, Iida M, Kruser TJ, Nechrebecki MM, Dunn EF, Armstrong EA, Huang S, Harari PM. Wheeler DL, et al. Cancer Biol Ther. 2009 Apr;8(8):696-703. doi: 10.4161/cbt.8.8.7903. Epub 2009 Apr 22. Cancer Biol Ther. 2009. PMID: 19276677 Free PMC article.

7

The role of Src in solid tumors.

Wheeler DL, Iida M, Dunn EF. Wheeler DL, et al. Oncologist. 2009 Jul;14(7):667-78. doi: 10.1634/theoncologist.2009-0009. Epub 2009 Jul 6. Oncologist. 2009. PMID: 19581523 Free PMC article. Review.

8

Nuclear EGFR contributes to acquired resistance to cetuximab.

Li C, Iida M, Dunn EF, Ghia AJ, Wheeler DL. Li C, et al. Among authors: wheeler dl. Oncogene. 2009 Oct 29;28(43):3801-13. doi: 10.1038/onc.2009.234. Epub 2009 Aug 17. Oncogene. 2009. PMID: 19684613 Free PMC article.

9

Mechanisms of resistance to HER family targeting antibodies.

Kruser TJ, Wheeler DL. Kruser TJ, et al. Among authors: wheeler dl. Exp Cell Res. 2010 Apr 15;316(7):1083-100. doi: 10.1016/j.yexcr.2010.01.009. Epub 2010 Jan 11. Exp Cell Res. 2010. PMID: 20064507 Review.

10

Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors.

Kruser TJ, Wheeler DL, Armstrong EA, Iida M, Kozak KR, van der Kogel AJ, Bussink J, Coxon A, Polverino A, Harari PM. Kruser TJ, et al. Among authors: wheeler dl. Clin Cancer Res. 2010 Jul 15;16(14):3639-47. doi: 10.1158/1078-0432.CCR-09-3385. Epub 2010 May 27. Clin Cancer Res. 2010. PMID: 20507929 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page